Page last updated: 2024-10-31

methylphenidate and Nasal Diseases

methylphenidate has been researched along with Nasal Diseases in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Blau-Most, M1
Nemet, AY1
Kidron, D1
Birnboim, G1
Kassem, F1

Other Studies

1 other study available for methylphenidate and Nasal Diseases

ArticleYear
Methylphenidate (Ritalin) abuse as new etiology of midline destructive lesions of the sinonasal tract: first report.
    International forum of allergy & rhinology, 2021, Volume: 11, Issue:7

    Topics: Humans; Methylphenidate; Nasal Septum; Nose Deformities, Acquired; Nose Diseases; Paranasal Sinuses;

2021